Company Filing History:
Years Active: 2021
Title: Rocio Vicario: Innovator in Bispecific T Cell Activating Molecules
Introduction
Rocio Vicario is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of immunology through his innovative work on bispecific antigen binding molecules. His research focuses on T cell activation and redirection to specific target cells, which has important implications for disease treatment.
Latest Patents
Rocio Vicario holds a patent for "Bispecific T cell activating antigen binding molecules." This invention relates to novel bispecific antigen binding molecules designed for T cell activation and redirection. The patent also encompasses polynucleotides encoding these molecules, as well as vectors and host cells that contain such polynucleotides. Furthermore, the invention outlines methods for producing these bispecific antigen binding molecules and their applications in treating various diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Rocio has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Rocio Vicario has collaborated with esteemed colleagues such as Christian Klein and Marina Bacac. These partnerships have enriched his research and expanded the impact of his innovations in the field of immunology.
Conclusion
Rocio Vicario is a key figure in the development of bispecific T cell activating molecules, with a focus on advancing treatment options for diseases. His innovative work and collaborations continue to shape the future of immunotherapy.